What is LOPJLB’s current signal on LYRA?

LOPJLB’s latest quantitative signal on Lyra Therapeutics, Inc. (LYRA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is LYRA in?

Lyra Therapeutics, Inc. (LYRA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Lyra Therapeutics, Inc. (LYRA) do?

Lyra Therapeutics, Inc. operates as a clinical-stage biotechnology company, primarily focused on the creation and commercialization of anti-inflammatory treatments for individuals suffering from chronic rhinosinusitis (CRS). The company's unique technological approach allows for the direct delivery of therapeutic agents to the targeted tissue, ensuring prolonged efficacy from a singular dose. I…

Where is Lyra Therapeutics, Inc. based / listed?

Lyra Therapeutics, Inc. is based in US, listed on OTC.

Lyra Therapeutics, Inc. (LYRA) Stock · SELL · CRISIS

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $17,749
Avg volume: 10.2K
Beta: 0.70
P/E (TTM): -0.00

Short % float: 0.31%
Days to cover: 1.7
SI change: +1.9%

1W: -96.00%
1M: -98.08%
3M: -98.57%
YTD: -99.68%

vs SPY 1W: -94.81%
vs SPY 1M: -101.40%
vs SPY 3M: -100.96%
vs SPY YTD: -111.44%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Sector peers

Industry peers

Prediction markets

Company news